Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hematological disorders in children with Down syndrome.

Expert review of hematology - 1 Feb 2022

Triarico Silvia, Trombatore Giovanna, Capozza Michele Antonio, Romano Alberto, Mastrangelo Stefano, Attinà Giorgio, Maurizi Palma, Ruggiero Antonio

Abstract excerpt

INTRODUCTION: Hematological abnormalities are common in children with down syndrome (DS), mainly during childhood. AREAS COVERED: DS newborns can develop hematological benign conditions that resolve spontaneously within 1 -2 months. However, about 10% of them can present transient abnormal myelopoiesis (TAM), characterized by the presence of circulating blasts. About 80% of DS neonates with TAM undergo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Child
Share to Down Syndrome

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to GATA1 Transcription Factor

Share to Hematologic Diseases

Share to Infant, Newborn

Share to Leukemia, Myeloid, Acute

Share to Trisomy

Source

Identifiers

PMID: 35184659
DOI: 10.1080/17474086.2022.2044780

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hematological disorders in children with Down syndrome.PMID 35184659Read ↗

Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemiaSemantic proximity Read ↗

Recent advances in the understanding of transient abnormal myelopoiesis in Down syndromeSemantic proximity Read ↗

Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.Semantic proximity Read ↗

Down syndrome and leukemia: insights into leukemogenesis and translational targets.Semantic proximity Read ↗

Clinical and biological aspects of myeloid leukemia in Down syndrome.Semantic proximity Read ↗

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an UpdateSemantic proximity Read ↗

Down syndrome-associated leukaemias: current evidence and challengesSemantic proximity Read ↗

Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions.Semantic proximity Read ↗

Distinctive hematological abnormalities in East Asian neonates and children with Down syndrome.Semantic proximity Read ↗

Down syndrome preleukemia and leukemia.Semantic proximity Read ↗

Acute leukemia in children with Down syndromeSemantic proximity Read ↗

Myeloid Leukemia in Down SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.